Introduction and Genetic Correction of Calreticulin Mutations in Human Hematopoietic Stem and Progenitor Cells Sheds Light on MPN Pathogenesis
Johannes Foßelteder(Medical University of Graz), Andreas Reinisch(Stem Cell Institute), Gabriel Pabst(Research Institute of Molecular Pathology), Karl Kashofer(Medical University of Graz), Armin Zebisch(Medical University of Graz), Bettina Amtmann(Medical University of Graz), Heinz Sill(Medical University of Graz), Albert Woelfler(University of Graz), Angelika Schlacher(Medical University of Graz), Christine Beham‐Schmid(Medical University of Graz), Hildegard Greinix(Medical University of Graz), Wolfgang Schöll(Medical University of Graz), Peter Schlenke(Medical University of Graz)
Cited by 0
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
|Brain Behavior and Immunity|2016|741
Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells
|Transfusion|2007|507
Inferring expressed genes by whole-genome sequencing of plasma DNA
|Nature Genetics|2016|463
One million haemopoietic stem-cell transplants: a retrospective observational study
|The Lancet Haematology|2015|434